AstraZeneca facing two London lawsuits over COVID vaccines Ruchika Sharma24 Aug 2023 11:37 AM ISTThe two cases are the first lawsuits brought in England and Wales over an adverse reaction to a COVID 19 vaccine, according to publicly available...
AstraZeneca Forxiga approved in China to reduce cardiovascular death, hospitalisation risk in adults with symptomatic chronic heart failure Ruchika Sharma20 Aug 2023 1:30 PM ISTForxiga is a first-in-class, oral, once-daily selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2).
CDSCO Panel Approves AstraZeneca's Phase III CT proposal For COPD Drug Tozorakimab Dr. Divya Colin19 Aug 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca gets CDSCO Panel Nod To Import, Market Palivizumab solution for injection Dr. Divya Colin17 Aug 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Dr Reddy's Labs unveils Saxagliptin, Metformin Hydrochloride ER Tablets in US Ruchika Sharma11 Aug 2023 12:30 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has announced its launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S....
Sanofi-AstraZeneca Beyfortus gets unanimous US CDC Advisory Committee recommendation to prevent RSV in neonates, infants Ruchika Sharma4 Aug 2023 1:09 PM ISTParis: Sanofi has recently announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization...
AstraZeneca gets right to commercialize Eplontersen in Latin America Ruchika Sharma1 Aug 2023 1:30 PM ISTAstraZeneca paid Ionis USD 20 million to license eplontersen in Latin America.
AstraZeneca names Sharon Barr as Executive Vice President BioPharmaceuticals RnD Ruchika Sharma29 July 2023 11:38 AM ISTCambridge: AstraZeneca has announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Sharon will succeed Mene...
AstraZeneca Soliris approved in EU for children, adolescents with refractory generalised myasthenia gravis Ruchika Sharma28 July 2023 2:30 PM ISTSoliris (eculizumab) is a first-in-class C5 complement inhibitor.
UK probes Novo Nordisk Ozempic, Saxenda over suicidal, self-harming thoughts Ruchika Sharma27 July 2023 2:30 PM ISTLondon: Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients...
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
AstraZeneca, Daiichi Sankyo gets Chinese nod for Enhertu as first HER2-directed therapy for patients with HER2-low metastatic breast cancer Ruchika Sharma16 July 2023 1:00 PM ISTEnhertu is a HER2-directed ADC.
